Jordi Vengohechea Llorens

Dr. Jordi Vengohechea Llorens

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
APArnau Panisello-Rosello
Arnau Panisello-Rosello
Teresa CarbonellTeresa Carbonell
Teresa Carbonell
Joan Rosello-CatafauJoan Rosello-Catafau
Joan Rosello-Catafau
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
AHAmelia Hessheimer
Amelia Hessheimer
CFConstantino Fondevila
Constantino Fondevila
Static cold storage (SCS) remains the most widely used method of liver graft preservation due to its simplicity, accessibility, and reduced cost in transplantation practice. Since the invention of the University of Wisconsin (UW) solution, several alternative preservation solutions—including histidine–tryptophan–ketoglutarate (HTK), Celsior, and more recently IGL-1 and IGL-2—have been formulated to optimize cellular and vascular protection during cold ischemia. More recently, the introduction of dynamic perfusion techniques, such as hypothermic oxygenated perfusion (HOPE) and normothermic machine perfusion (NMP), approximately fifteen years ago, has further enhanced transplantation protocols, being applied either alone or in combination with traditional SCS to ensure optimal graft preservation prior to implantation. Despite these technological advances, achieving fully effective dynamic perfusion remains a key challenge for improving outcomes in vulnerable grafts, particularly steatotic or marginal livers. This review details how Polyethylene Glycol 35 (PEG35)-based solutions activate multiple cytoprotective pathways during SCS, including AMP-activated protein kinase (AMPK), nitric oxide (NO) production, and the antioxidant transcription factor Nrf2. We propose that these molecular mechanisms serve as a form of preconditioning that is synergistically leveraged by HOPE to preserve mitochondrial function, endothelial glycocalyx integrity, and microvascular homeostasis. Furthermore, the oncotic and rheological properties of PEG35 reduce perfusate viscosity, mitigating shear stress and microcirculatory damage during dynamic perfusion—effects that are further enhanced by NO- and AMPK-mediated protection initiated during the SCS phase. This integrated approach provides a strong rationale for combining PEG35-mediated SCS with HOPE, particularly for grafts with high susceptibility to ischemia–reperfusion injury, such as fatty livers. Finally, we highlight emerging avenues in graft preservation, including the design of unified perfusion solutions that optimize endothelial, mitochondrial, and redox protection, with the potential to improve post-transplant outcomes and extend applicability to other solid organ grafts.

7 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
AHAmelia Hessheimer
Amelia Hessheimer
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
LMLilia Martínez de la Maza
Lilia Martínez de la Maza
JLJavier Muñoz Luque
Javier Muñoz Luque
MVMarina Vendrell
Marina Vendrell
CFConstantino Fondevila
Constantino Fondevila
Liver resection treats primary and secondary liver tumors, though clinical applicability is limited by the remnant liver mass and quality. Herein, major hepatic resections were performed in pigs to define changes associated with sufficient and insufficient remnants and improve liver-specific outcomes with somatostatin therapy. Three experimental groups were performed: 75% hepatectomy (75H), 90% hepatectomy (90H), and 90% hepatectomy + somatostatin (90H + SST). Animals were followed for 24 h (N = 6) and 5 d (N = 6). After hepatectomy, portal pressure gradient was higher in 90H versus 75H and 90H + SST (8 (3–13) mmHg vs. 4 (2–6) mmHg and 4 (2–6) mmHg, respectively, p < 0.001). After 24 h, changes were observed in 90H associated with stellate cell activation and collapse of sinusoidal lumen. Collagen chain type 1 alpha 1 mRNA expression was higher, extracellular matrix width less, and percentage of collagen-staining areas greater at 24 h in 90H versus 75H and 90H + SST. After 5 d, remnant liver mass was higher in 75H and 90H + SST versus 90H, and Ki-67 immunostaining was higher in 90H + SST versus 75H and 90H. As well, more TUNEL-staining cells were observed in 90H versus 75H and 90H + SST at 5 d. Perioperative somatostatin modified portal pressure, injury, apoptosis, and stellate cell activation, stemming changes related to hepatic fibrogenesis seen in liver remnants not receiving treatment.

29 January 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
AHAmelia Hessheimer
Amelia Hessheimer
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
CFConstantino Fondevila
Constantino Fondevila
Click on the article title to read more.

30 December 2025 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
SRSoraya Rodríguez
Soraya Rodríguez
AIAlicia Izquierdo
Alicia Izquierdo
JLJavier Muñoz Luque
Javier Muñoz Luque
PBPaula P. Burgos
Paula P. Burgos
CFConstantino Fondevila
Constantino Fondevila
Ex situ normothermic machine perfusion (NMP) of the liver has emerged as a dynamic preservation strategy, enabling the maintenance of metabolic activity and assessment of grafts prior to transplantation. Prolonged perfusions, however, are limited by the accumulation of metabolic waste, electrolyte imbalances, and inflammatory mediators that can compromise graft function. Continuous renal replacement therapies (CRRT), especially continuous venovenous hemodiafiltration (CVVHDF), offer a potential means to support solute clearance and homeostatic regulation during extended perfusion periods. In this protocol, we describe a reproducible and safe method for integrating CVVHDF into an ex situ liver NMP system by connecting the filtration circuit independently from the main organ perfusion circuit. This configuration supports hemodynamic stability, helps prevent excessive intravascular pressures, and may reduce the risk of tissue edema. The physical connection, priming, and monitoring of the CRRT circuit are explained in detail, along with instructions on how to utilize a Hoffman clamp to simulate physiological venous pressure. When compared to direct in-line circuit integration, representative results suggest that the out-of-circuit approach is associated with reduced graft edema, while maintaining stable circuit pressure and solute clearance. This approach can be easily integrated into other similar perfusion devices in order to improve solute handling while maintaining stable perfusion dynamics.

5 March 2026 in JHEP Reports
Verified
Journal Article
Open access
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
AHAmelia Hessheimer
Amelia Hessheimer
JMJavier Muñoz
Javier Muñoz
JAJoaquim Albiol
Joaquim Albiol
MVMarina Vendrell
Marina Vendrell
CFConstantino Fondevila
Constantino Fondevila
Performing ex situ normothermic machine perfusion (NMP) for ≥24 h represents an opportunity to evaluate and treat livers, but is limited by the lack of support from relevant extrahepatic organs. Incorporation of systems of renal replacement therapy, including hemodiafiltration (HDF), appears useful in this regard during prolonged ex situ liver NMP. This study aimed to demonstrate the impact and benefits associated with incorporation of continuous HDF during 24-h ex situ NMP in a relevant preclinical model, including transplantation and post-transplant follow-up. Porcine livers (n = 28) underwent 24-h ex situ NMP with either partial perfusate exchange at 12 h and no HDF (NHDF, n = 11) or HDF initiated 2 h after NMP start (n = 17). Biochemical, histological, endothelial, and metabolomic parameters were assessed. A subset of grafts undergoing NMP + HDF (n = 8) were transplanted into recipients. Incorporation of HDF during NMP maintained stable pH and electrolyte levels, effectively preventing hypernatremia, hypochloremia, and hypocalcemia developing without HDF. HDF cleared metabolic wastes (e.g. urea) and inflammatory cytokines (IL-1B, IL-2, IL-6, IL-8, and IL-18), resulting in reduced injury and oxidative stress markers after 24 h (Suzuki score 0.8 ± 0.4 HDF vs. 2.7 ± 1.3 NHDF, p <0.001). Vasoprotective endothelial response mechanisms, including KLF2 and eNOS gene and protein expression, were upregulated, whereas stellate cell activation and sinusoidal contraction were reduced among HDF-treated grafts. HDF reduced metabolomic alterations arising in livers during 24-h NMP, and adequate graft maintenance using NMP + HDF was demonstrated by full functional and metabolic recovery during post-transplant follow-up. Continuous HDF promotes a more physiological biochemical and metabolic environment, reduces inflammation and oxidative stress, and preserves homeostatic endothelial response mechanisms in livers undergoing 24-h ex situ NMP, facilitating successful transplantation in a complex preclinical model. In this preclinical study, livers were normothermically perfused for 24 h ex situ, both with and without continuous HDF. Incorporation of HDF offered relevant improvements in numerous on-device measures, including the maintenance of physiological biochemical parameters; removal of injurious metabolic wastes; and improvement of injury and stress responses in parenchymal and nonparenchymal cells. A subset of livers were successfully transplanted and demonstrated full functional and metabolic recovery during follow-up. These findings indicate that advanced renal replacement therapies, such as HDF, are a key aspect of improving and prolonging ex situ normothermic liver perfusion, although there is ongoing need to develop more physiological metabolic support protocols for livers while on such devices.

31 August 2026 in American Journal of Transplantation
Verified
Journal Article
Closed access
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
LWLinda Woltjes
Linda Woltjes
Germaine EscamesGermaine Escames
Germaine Escames
VMVincent E. de Meijer
Vincent E. de Meijer
AHAmelia Hessheimer
Amelia Hessheimer
CFConstantino Fondevila
Constantino Fondevila